News for The Hackett Group, Inc. (HCKT)

Total Revenue: $79.2 million for Q4 2024.Adjusted Earnings Per Share (EPS): $0.47, exceeding quarterly guidance.Global S&BT Segment Revenue: $43.9 million, wit

The Hackett Group, Inc. (NASDAQ:HCKT) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ETCompany ParticipantsRob Ramirez - Chief Financial...

Revenue: Achieved $79.2 million in total revenue for Q4 2024, surpassing the estimated $75.69 million.Adjusted EPS: Reported $0.47, exceeding the estimated $0.

[url="]The Hackett Group[/url], Inc. (NASDAQ: HCKT), an IP platform-based, Gen AI strategic consulting and executive advisory firm that enables Digital World C

The Hackett Group Inc (HCKT) is set to release its Q4 2024 earnings on Feb 18, 2025. The consensus estimate for Q4 2024 revenue is $75.69 million, and the earni

**media[532712]**

Q3 2024 trends: volatility in natural gas, bullish precious metals, coal turnaround potential, and shifting dynamics in oil, agriculture, and base metals.

According to new research from [url="]The Hackett Group, Inc.[/url] (NASDAQ: HCKT), Digital World Class® human resources (HR) organizations have continued to

Goehring & Rozencwajg have published their Q3 2024 Natural Resource Market Commentary. Click here to read the full commentary.

We recently compiled a list of the 10 AI News Making Waves Today. In this article, we are going to take a look at where The Hackett Group, Inc.

Operator: Welcome to The Hackett Group Third Quarter Earnings Conference Call. Your lines have been placed on a listen-only mode until the question-and-answer session.

Earnings call: Hackett Group Beats Q3 Guidance with Strong GenAI Growth

The Hackett Group, Inc. (NASDAQ:HCKT) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ETCompany ParticipantsRob Ramirez - CFOTed Fernandez -...

Overview of the Recent Transaction On September 30, 2024, the investment firm managed by Chuck Royce (Trades, Portfolio) executed a significant transaction invo

The Hackett Group unveils AI XPLR 2.0 platform

Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see the companies with upcoming ex-dividend dates.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of October 1.

Sign up for our FREE Newsletter and get: The Beginner’s Handbook For…

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.